GE Healthcare: EPS down 10% in Q4

(CercleFinance.com) - GE Healthcare reports adjusted EPS of $1.
18 for Q4 2023, down 10% y-o-y, with an adjusted EBIT margin stable at 16.1%, as productivity and pricing gains offset investments.

The medical technology supplier's sales rose 5% to $5.2bn, driven by both pricing and volumes, while orders grew organically by 3%, leaving a solid book-to-bill ratio at 1.05x.

For FY 2024, GE Healthcare anticipates adjusted EPS of $4.20 to $4.35 (vs. $3.93 for FY 2023), an adjusted EBIT margin of between 15.6% and 15.9%, and organic sales growth of around 4%.


Copyright (c) 2024 CercleFinance.com. All rights reserved.